Bio Essence annual free cash flow
2020
2021
2022
2023
Bio Essence Free Cash Flow (FCF) History (BIOE)
Bio Essence reported −$1.0M in free cash flow for fiscal 2023, a decrease of $322,304 from the previous fiscal year, with a free cash flow margin of −186.63%.
View full Bio Essence company overviewBio Essence free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$1.0M | −$322,304 | — | −186.63% |
| 2022 | 2022-12-31 | −$706,983 | $706,631 | — | −113.74% |
| 2021 | 2021-12-31 | −$1.4M | −$673,505 | — | −159.19% |
| 2020 | 2020-12-31 | −$740,109 | — | — | −77.20% |
Bio Essence quarterly free cash flow
Q1.21
Q2.21
Q3.21
Q4.21
Q3.22
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2022 | 2022-09-30 | −$182,331 | −$14,155 | — | −94.94% |
| Q4 2021 | 2021-12-31 | −$232,412 | — | — | −109.09% |
| Q3 2021 | 2021-09-30 | −$182,143 | — | — | −80.24% |
| Q2 2021 | 2021-06-30 | −$830,883 | — | — | −352.18% |
| Q1 2021 | 2021-03-31 | −$168,176 | — | — | −79.32% |
Bio Essence free cash flow growth trends
Bio Essence's latest reported quarter, Q3 2022, generated −$182,331 in free cash flow, a decrease of $14,155 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Bio Essence filings at SEC.gov ↗